INTRODUCTION
The explosive increase of Diabetic population worldwide is a major public health concern both in developing and developed countries. Metabolic syndrome is also on an increasing trend. The metabolic syndrome is closely linked to insulin resistance and numerous studies indicate a link to iron overload. Increased serum ferritin, reflecting body iron overload, is often associated with measures of insulin resistance, such as elevated blood glucose and insulin levels. 1 In addition, two prospective studies have identified an independent association between baseline elevations in iron stores and the incidence of diabetes. 2, 3 Elevated iron stores may induce diabetes through a variety of mechanisms, including oxidative damage to pancreatic beta cells, impairment of hepatic insulin extraction by the liver, and interference with insulin's ability to suppress hepatic glucose production.
Hence this study was carried out to examine the relationship between serum ferritin and type 2 diabetes mellitus and metabolic syndrome and to establish a correlation between S. ferritin and FBS, HbA1c.
METHODS
The study was designed as a case control study. The study was conducted over a period of one year. Eighty six type 2 diabetes patients who were treated on an outpatient basis in Trivandrum were included in the study. Age and sex matched normal healthy controls were selected for the study.
Inclusion criteria
Diagnosed type 2 diabetes mellitus patients on treatment, in the age group-45-65 years. Control: Healthy controls in the age group 45-65 years.
Exclusion criteria
Overt thyroid dysfunction Chronic kidney disease Chronic liver disease On corticosteroid therapy
Data collection
A detailed proforma was filled up for each patient which included age, sex, past history of coronary artery disease, cerebrovascular accident, history of hypertension. The age of onset and duration of diabetes was recorded. As also recorded was whether the patient was treated with oral hypoglycemic agents or insulin or whether the patient was on diet control alone.
Laboratory parameters including Serum ferritin, Hemoglobin, ESR, fasting and postprandial blood sugar, glycosylated hemoglobin, renal function tests, liver function tests, serum total cholesterol, serum triglycerides, LDL cholesterol, HDL cholesterol were estimated.
A detailed physical examination was done which included measuring height and weight and waist circumference. BMI was estimated. Blood pressure was recorded with a standard manometer using WHO guidelines. Metabolic syndrome and dyslipidemia were diagnosed using the National Cholesterol Education Programme ATP III guidelines. Hypertension was diagnosed and classified according to the JNC VII criteria. A fasting plasma glucose ≥126 mg/dl or previous history of diabetes mellitus was required for the diagnosis of diabetes.
Blood was collected from patients after an overnight (8 hr) fasting and 2 hr postprandial (after a breakfast meal).
RESULTS
Majority of the patients with diabetes were male (66% vs. 34%). The mean age group of patients with diabetes was 54.3±9.2 years and that of the controls is 53.5±10.7 years. 24 % of the patients in the cases group had a past history of coronary artery disease or cerebrovascular accident compared to 8 % of the controls (p<0.001). Systemic hypertension was seen to be significantly higher in the cases (22% of the cases and 12% of the controls were hypertensives, p< 0.001).The age of onset of diabetes in 80% of patients was between 44 and 48 years. The duration of diabetes was between 5-10 years in 49% and more than 10 years in 36%. 67% of the patients were on oral hypoglycemic agents and 21% were on insulin. The lipid profiles showed significantly higher levels of total cholesterol (p<0.05) and serum triglyceride (p<0.01) in the cases compared to the controls. The HDL, LDL cholesterol levels were not significantly different in the two groups. Serum ferritin was significantly higher in the cases (p<0.01) when compared to controls. Serum ferritin was significantly related to the duration of diabetes (p<0.05).
As the duration of diabetes increased, serum ferritin also increased. There was a positive correlation between serum ferritin and FBS, HbA1c. Serum ferritin is significantly related to FBS (r-0.909, p<0.01) in cases. Serum ferritin is also significantly related to HbA1c (r-0.209, p<0.05). There was no correlation between S. ferritin and age, sex, BMI, metabolic syndrome, coexistent hypertension, total cholesterol, LDL and serum triglycerides. 
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DISCUSSION
The study population consisted of predominant male diabetics with mean age of 54.3 years. Most of the patients were on oral hypoglycemic agents. Only about 10 % of patients were untreated.
Serum ferritin, a reflector of body iron stores was significantly higher in diabetic patients when compared to controls and this significantly increased as duration of diabetes increased. This possibly reflects the subclinical hemochromatosis developing in a long standing diabetic patient. 9 Fernandez et al 10 in their studies concluded that increased body iron stores are possibly associated with occurrence of glucose intolerance, type-2 diabetes and gestational diabetes.
Serum Ferritin had a positive correlation with FBS and HbA1c. This reflected the relation between serum ferritin and glycaemic control, both short term and long term. Cantur KZ et al 11 confirmed in their studies that poorly controlled diabetes patients had hyperferritinemia. This showed that serum ferritin was increased in diabetes as long as glycemic control was not achieved. They also found a correlation between ferritin level and diabetic retinopathy. In diabetic subjects, a positive correlation between increased serum ferritin and poor glycemic control, reflected by higher HbAIc, has been suggested by Eschwege et al. 12 Our study showed no correlation between serum ferritin and BMI and with metabolic syndrome in diabetic patients. There was also no correlation between S. ferritin and age, sex, coexistent hypertension, total cholesterol, LDL and serum triglycerides. Metabolic syndrome or syndrome X are terms used to describe constellation of metabolic derangements that include insulin resistance, hypertension, dyslipidemia with low HDL and elevated triglycerides, obesity, type 2 diabetes mellitus and accelerated cardiovascular disease. Iron stores expressed as serum ferritin concentration, have been proposed as component of insulin resistance syndrome. Wrede et al 13 suggested that serum ferritin values are significantly increased in men and women with high BMI (>25 kg/m 2 ), increased cholesterol (>200 mg/dl), and increased systolic (>160 mmHg) blood pressure, in women with diabetes, and in men with increased diastolic (>95 mmHg) blood pressure. Our study disproves this proposition.
To conclude, the major issue arises whether to estimate S. ferritin routinely in all type 2 diabetes patients and whether to set a cutoff value of serum ferritin for good glycaemic control. Though our study is a pointer in this direction, we would recommend further studies in this path for setting up specific guidelines.
